Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Prevalence of Germline Pathogenic <i>RET</i> Variants in a Pan-Cancer Patient Population.

JCO precision oncology·2026

Same author

Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis.

The oncologist·2026

Same author

<i>NTRK</i> Gene Fusions: A Compendium of Fusion Partners and Tumor Types.

JCO precision oncology·2026

Same author

Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Molecular lineages of sporadic mismatch-repair deficient colorectal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Search research articles

Related Experiment Video

Updated: Jun 24, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Optimus-Era Dose Finding for Rare Cancers.

Yonina R Murciano-Goroff¹, Sean M Devlin¹, Alexia Iasonos¹

¹Memorial Sloan Kettering Cancer Center, New York, New York.

Cancer Discovery

|June 3, 2024

Summary

Developing new cancer drugs is hard for rare subtypes. This study proposes dose-finding strategies for small patient groups, aligning with FDA Project Optimus guidelines.

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Related Experiment Videos

Last Updated: Jun 24, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Area of Science:

Oncology
Clinical Pharmacology
Drug Development

Background:

Growing recognition of rare cancer subtypes necessitates accelerated drug development.
Small patient populations in rare cancers present unique challenges for clinical trials.

Purpose of the Study:

To address the challenges of dose finding in rare cancer clinical trials.
To propose strategies for dose optimization in rare cancers.
To align dose-finding approaches with the US Food and Drug Administration's Project Optimus.

Main Methods:

Review of current dose-finding methodologies.
Analysis of challenges specific to rare cancer trials.
Proposal of adaptive and innovative dose optimization strategies.

Main Results:

Identified key dose-finding challenges in rare cancer trials.
Outlined practical strategies for optimizing drug dosage in small patient cohorts.
Provided a framework for dose determination aligned with Project Optimus.

Conclusions:

Effective dose finding in rare cancers requires tailored strategies.
Proposed methods facilitate efficient drug development for rare cancer patients.
Alignment with Project Optimus ensures modern, optimized dose determination.